Bcr phosphorylated on tyrosine 177 binds Grb2 View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1997-05-15

AUTHORS

Guozhen Ma, Dai Lu, Yun Wu, Jiaxin Liu, Ralph B Arlinghaus

ABSTRACT

We and others have shown that the Bcr-Abl oncoprotein binds activators of the Ras pathway such as Grb2 and Shc. Grb2 binding is mediated through a phosphorylated tyrosine residue (Y177) located within a consensus Grb2 binding site encoded by the first exon of the BCR gene. Our results indicate that P160 BCR is tyrosine phosphorylated at the same site by Bcr-Abl in kinase assays (Puil et al., 1994). We performed experiments to determine whether Bcr, which was tyrosine phosphorylated within cells by activated c-Abl, could also bind Grb2, and whether phosphotyrosine 177 was the major binding site. Complexes between Bcr and Abl were detected in a hemopoietic cell line lacking Bcr-Abl and in COS1 cells coexpressing both Bcr and Abl proteins. P160 BCR was tyrosine phosphorylated in COS1 cells coexpressing Abl and Bcr proteins. Similarly, various deletion mutants of Bcr including BCRN553, BCRN413 and BCRN221 were tyrosine phosphorylated by activated c-Abl whereas BCRN159 was not. Wild-type Bcr and Bcr Y177F were examined under these conditions for their ability to co-precipitate with Grb2. The results showed that while wild-type tyrosine phosphorylated Bcr efficiently bound Grb2, tyrosine phosphorylated Bcr Y177F had greatly reduced Grb2-binding ability. Studies with GST-SH2 (Grb2) revealed that tyrosine phosphorylated Bcr was able to bind to GST SH2 (Grb2) but tyrosine phosphorylated Bcr Y177F was deficient in binding. These results indicate that the Bcr protein when phosphorylated at tyrosine 177 binds Grb2, thereby implicating Bcr as a potantial activator of the Ras pathway. More... »

PAGES

2367-2372

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.onc.1201053

DOI

http://dx.doi.org/10.1038/sj.onc.1201053

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002043356

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9178913


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adaptor Proteins, Signal Transducing", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "COS Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "GRB2 Adaptor Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glutathione Transferase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphorylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Binding", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein-Tyrosine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-bcr", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tyrosine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "src Homology Domains", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.267308.8", 
          "name": [
            "Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ma", 
        "givenName": "Guozhen", 
        "id": "sg:person.0577133700.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577133700.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.267308.8", 
          "name": [
            "Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lu", 
        "givenName": "Dai", 
        "id": "sg:person.01201261340.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201261340.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.267308.8", 
          "name": [
            "Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wu", 
        "givenName": "Yun", 
        "id": "sg:person.010674076317.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010674076317.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.267308.8", 
          "name": [
            "Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Jiaxin", 
        "id": "sg:person.014655734747.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014655734747.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA", 
          "id": "http://www.grid.ac/institutes/grid.267308.8", 
          "name": [
            "Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arlinghaus", 
        "givenName": "Ralph B", 
        "id": "sg:person.01024061632.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024061632.28"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1997-05-15", 
    "datePublishedReg": "1997-05-15", 
    "description": "We and others have shown that the Bcr-Abl oncoprotein binds activators of the Ras pathway such as Grb2 and Shc. Grb2 binding is mediated through a phosphorylated tyrosine residue (Y177) located within a consensus Grb2 binding site encoded by the first exon of the BCR gene. Our results indicate that P160 BCR is tyrosine phosphorylated at the same site by Bcr-Abl in kinase assays (Puil et al., 1994). We performed experiments to determine whether Bcr, which was tyrosine phosphorylated within cells by activated c-Abl, could also bind Grb2, and whether phosphotyrosine 177 was the major binding site. Complexes between Bcr and Abl were detected in a hemopoietic cell line lacking Bcr-Abl and in COS1 cells coexpressing both Bcr and Abl proteins. P160 BCR was tyrosine phosphorylated in COS1 cells coexpressing Abl and Bcr proteins. Similarly, various deletion mutants of Bcr including BCRN553, BCRN413 and BCRN221 were tyrosine phosphorylated by activated c-Abl whereas BCRN159 was not. Wild-type Bcr and Bcr Y177F were examined under these conditions for their ability to co-precipitate with Grb2. The results showed that while wild-type tyrosine phosphorylated Bcr efficiently bound Grb2, tyrosine phosphorylated Bcr Y177F had greatly reduced Grb2-binding ability. Studies with GST-SH2 (Grb2) revealed that tyrosine phosphorylated Bcr was able to bind to GST SH2 (Grb2) but tyrosine phosphorylated Bcr Y177F was deficient in binding. These results indicate that the Bcr protein when phosphorylated at tyrosine 177 binds Grb2, thereby implicating Bcr as a potantial activator of the Ras pathway.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.onc.1201053", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438826", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2472167", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "19", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "keywords": [
      "Ras pathway", 
      "COS1 cells", 
      "GST-SH2", 
      "Bcr protein", 
      "c-Abl", 
      "phosphorylated tyrosine residues", 
      "P160 BCR", 
      "hemopoietic cell lines", 
      "wild type Bcr", 
      "bind Grb2", 
      "kinase assays", 
      "deletion mutants", 
      "Grb2", 
      "first exon", 
      "Grb2 binding", 
      "tyrosine residues", 
      "ABL protein", 
      "major binding site", 
      "BCR-ABL", 
      "Bcr-Abl oncoprotein", 
      "binding sites", 
      "cell lines", 
      "protein", 
      "tyrosine", 
      "BCR", 
      "activator", 
      "BCR gene", 
      "wild-type tyrosine", 
      "pathway", 
      "cells", 
      "ABL", 
      "same site", 
      "SH2", 
      "Shc", 
      "mutants", 
      "exons", 
      "sites", 
      "genes", 
      "oncoprotein", 
      "binds", 
      "residues", 
      "binding", 
      "assays", 
      "complexes", 
      "ability", 
      "lines", 
      "results", 
      "experiments", 
      "conditions", 
      "study"
    ], 
    "name": "Bcr phosphorylated on tyrosine 177 binds Grb2", 
    "pagination": "2367-2372", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002043356"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.onc.1201053"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9178913"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.onc.1201053", 
      "https://app.dimensions.ai/details/publication/pub.1002043356"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_279.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.onc.1201053"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201053'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201053'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201053'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1201053'


 

This table displays all metadata directly associated to this object as RDF triples.

199 TRIPLES      20 PREDICATES      89 URIs      80 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.onc.1201053 schema:about N215de779d5984370b1238859b3484137
2 N3c7842dd912041dd82e89a2436fb623a
3 N5351941d555846ca8891964fcdaf42ad
4 N64ead6b721e941da974cf8dc1b231b0e
5 N7477a2e388b1441f822b4d8cdf8e3bda
6 N81031a48df3f4cae99c95071e2b1f251
7 N8bfb6a3abe88406cb2096fe74cd66fd2
8 Na7ca978667624e5b8aa8341c5a2e13c1
9 Na9044e012d3a4d47b9c4018c3adc17d8
10 Nbcfe79178db34f49ae9977970d038aa5
11 Nc966352f889c48bbbc8c798d8881bd44
12 Ne027835d589d48f099dad288caabe596
13 Nfb947be44b2a4d938896341b82ea871c
14 anzsrc-for:11
15 anzsrc-for:1103
16 anzsrc-for:1112
17 schema:author Ne2351b62f33f40a0bc25af47398bfdde
18 schema:datePublished 1997-05-15
19 schema:datePublishedReg 1997-05-15
20 schema:description We and others have shown that the Bcr-Abl oncoprotein binds activators of the Ras pathway such as Grb2 and Shc. Grb2 binding is mediated through a phosphorylated tyrosine residue (Y177) located within a consensus Grb2 binding site encoded by the first exon of the BCR gene. Our results indicate that P160 BCR is tyrosine phosphorylated at the same site by Bcr-Abl in kinase assays (Puil et al., 1994). We performed experiments to determine whether Bcr, which was tyrosine phosphorylated within cells by activated c-Abl, could also bind Grb2, and whether phosphotyrosine 177 was the major binding site. Complexes between Bcr and Abl were detected in a hemopoietic cell line lacking Bcr-Abl and in COS1 cells coexpressing both Bcr and Abl proteins. P160 BCR was tyrosine phosphorylated in COS1 cells coexpressing Abl and Bcr proteins. Similarly, various deletion mutants of Bcr including BCRN553, BCRN413 and BCRN221 were tyrosine phosphorylated by activated c-Abl whereas BCRN159 was not. Wild-type Bcr and Bcr Y177F were examined under these conditions for their ability to co-precipitate with Grb2. The results showed that while wild-type tyrosine phosphorylated Bcr efficiently bound Grb2, tyrosine phosphorylated Bcr Y177F had greatly reduced Grb2-binding ability. Studies with GST-SH2 (Grb2) revealed that tyrosine phosphorylated Bcr was able to bind to GST SH2 (Grb2) but tyrosine phosphorylated Bcr Y177F was deficient in binding. These results indicate that the Bcr protein when phosphorylated at tyrosine 177 binds Grb2, thereby implicating Bcr as a potantial activator of the Ras pathway.
21 schema:genre article
22 schema:isAccessibleForFree false
23 schema:isPartOf Naea571be9d8142d18328e2b69d812b10
24 Ncd3e1309a4f44daa9f52fb1805dc0da9
25 sg:journal.1097543
26 schema:keywords ABL
27 ABL protein
28 BCR
29 BCR gene
30 BCR-ABL
31 Bcr protein
32 Bcr-Abl oncoprotein
33 COS1 cells
34 GST-SH2
35 Grb2
36 Grb2 binding
37 P160 BCR
38 Ras pathway
39 SH2
40 Shc
41 ability
42 activator
43 assays
44 bind Grb2
45 binding
46 binding sites
47 binds
48 c-Abl
49 cell lines
50 cells
51 complexes
52 conditions
53 deletion mutants
54 exons
55 experiments
56 first exon
57 genes
58 hemopoietic cell lines
59 kinase assays
60 lines
61 major binding site
62 mutants
63 oncoprotein
64 pathway
65 phosphorylated tyrosine residues
66 protein
67 residues
68 results
69 same site
70 sites
71 study
72 tyrosine
73 tyrosine residues
74 wild type Bcr
75 wild-type tyrosine
76 schema:name Bcr phosphorylated on tyrosine 177 binds Grb2
77 schema:pagination 2367-2372
78 schema:productId N0481c29ea35d4a329c079f7c012237fe
79 N08007628ecf54594880cf489f04fd672
80 N20b9216c96dc44e29231fb3d741d68e3
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002043356
82 https://doi.org/10.1038/sj.onc.1201053
83 schema:sdDatePublished 2022-10-01T06:30
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher N93b23737a7ae403a8614e37dcc3e60f8
86 schema:url https://doi.org/10.1038/sj.onc.1201053
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N0481c29ea35d4a329c079f7c012237fe schema:name dimensions_id
91 schema:value pub.1002043356
92 rdf:type schema:PropertyValue
93 N08007628ecf54594880cf489f04fd672 schema:name doi
94 schema:value 10.1038/sj.onc.1201053
95 rdf:type schema:PropertyValue
96 N09aab1efb89645b3898edc388bd6f479 rdf:first sg:person.01024061632.28
97 rdf:rest rdf:nil
98 N20b9216c96dc44e29231fb3d741d68e3 schema:name pubmed_id
99 schema:value 9178913
100 rdf:type schema:PropertyValue
101 N215de779d5984370b1238859b3484137 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Proto-Oncogene Proteins
103 rdf:type schema:DefinedTerm
104 N24046551f06c48ae8d7eb57609619014 rdf:first sg:person.01201261340.05
105 rdf:rest Nd68eb2eee94b4b2cbacc4fb07366fb99
106 N3c7842dd912041dd82e89a2436fb623a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Phosphorylation
108 rdf:type schema:DefinedTerm
109 N5351941d555846ca8891964fcdaf42ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Proteins
111 rdf:type schema:DefinedTerm
112 N64ead6b721e941da974cf8dc1b231b0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Protein Binding
114 rdf:type schema:DefinedTerm
115 N7477a2e388b1441f822b4d8cdf8e3bda schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Protein-Tyrosine Kinases
117 rdf:type schema:DefinedTerm
118 N81031a48df3f4cae99c95071e2b1f251 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Tyrosine
120 rdf:type schema:DefinedTerm
121 N8bfb6a3abe88406cb2096fe74cd66fd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Glutathione Transferase
123 rdf:type schema:DefinedTerm
124 N93b23737a7ae403a8614e37dcc3e60f8 schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 Na7ca978667624e5b8aa8341c5a2e13c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Animals
128 rdf:type schema:DefinedTerm
129 Na9044e012d3a4d47b9c4018c3adc17d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Adaptor Proteins, Signal Transducing
131 rdf:type schema:DefinedTerm
132 Naea571be9d8142d18328e2b69d812b10 schema:issueNumber 19
133 rdf:type schema:PublicationIssue
134 Nb815c36222b340329f1bc86d64ca9aaa rdf:first sg:person.014655734747.31
135 rdf:rest N09aab1efb89645b3898edc388bd6f479
136 Nbcfe79178db34f49ae9977970d038aa5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name src Homology Domains
138 rdf:type schema:DefinedTerm
139 Nc966352f889c48bbbc8c798d8881bd44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Proto-Oncogene Proteins c-bcr
141 rdf:type schema:DefinedTerm
142 Ncd3e1309a4f44daa9f52fb1805dc0da9 schema:volumeNumber 14
143 rdf:type schema:PublicationVolume
144 Nd68eb2eee94b4b2cbacc4fb07366fb99 rdf:first sg:person.010674076317.76
145 rdf:rest Nb815c36222b340329f1bc86d64ca9aaa
146 Ne027835d589d48f099dad288caabe596 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name COS Cells
148 rdf:type schema:DefinedTerm
149 Ne2351b62f33f40a0bc25af47398bfdde rdf:first sg:person.0577133700.44
150 rdf:rest N24046551f06c48ae8d7eb57609619014
151 Nfb947be44b2a4d938896341b82ea871c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name GRB2 Adaptor Protein
153 rdf:type schema:DefinedTerm
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
158 schema:name Clinical Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
161 schema:name Oncology and Carcinogenesis
162 rdf:type schema:DefinedTerm
163 sg:grant.2438826 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1201053
164 rdf:type schema:MonetaryGrant
165 sg:grant.2472167 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1201053
166 rdf:type schema:MonetaryGrant
167 sg:journal.1097543 schema:issn 0950-9232
168 1476-5594
169 schema:name Oncogene
170 schema:publisher Springer Nature
171 rdf:type schema:Periodical
172 sg:person.01024061632.28 schema:affiliation grid-institutes:grid.267308.8
173 schema:familyName Arlinghaus
174 schema:givenName Ralph B
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024061632.28
176 rdf:type schema:Person
177 sg:person.010674076317.76 schema:affiliation grid-institutes:grid.267308.8
178 schema:familyName Wu
179 schema:givenName Yun
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010674076317.76
181 rdf:type schema:Person
182 sg:person.01201261340.05 schema:affiliation grid-institutes:grid.267308.8
183 schema:familyName Lu
184 schema:givenName Dai
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201261340.05
186 rdf:type schema:Person
187 sg:person.014655734747.31 schema:affiliation grid-institutes:grid.267308.8
188 schema:familyName Liu
189 schema:givenName Jiaxin
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014655734747.31
191 rdf:type schema:Person
192 sg:person.0577133700.44 schema:affiliation grid-institutes:grid.267308.8
193 schema:familyName Ma
194 schema:givenName Guozhen
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577133700.44
196 rdf:type schema:Person
197 grid-institutes:grid.267308.8 schema:alternateName Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA
198 schema:name Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Centre, 77030, Houston, Texas, USA
199 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...